Search for: "Common Compounds, Inc." Results 81 - 100 of 370
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Jul 2019, 6:12 am by Patricia Hughes
The Tribunal referred to the Court of Appeal’s 2013 decision in Ontario (Alcohol and Gaming Commission of Ontario) v. 751809 Ontario Inc. [read post]
8 Jul 2019, 1:00 am by Adonis Hoffman, Esq.
  Each has its own set of priorities and there seems to be some common ground. [read post]
3 Jun 2019, 9:03 pm by News Desk
Bitter apricot kernels contain the compound amygdalin, which has the potential to release cyanide when the kernels are ingested. [read post]
19 May 2019, 9:04 pm by Laura Mushrush
  Crowley outlined four common pathogen testing methods. [read post]
11 Apr 2019, 10:59 am by Camilla Hrdy
A common example would be a claim to therapeutic efficacy in a specification that is not born out. [read post]
7 Jan 2019, 2:35 pm by Kevin LaCroix
Supreme Court issued its unanimous decision in Cyan, Inc. v. [read post]
11 Dec 2018, 5:31 am by Barry Sookman
Further, unlike in other Commonwealth countries significant copying can go uncompensated if the copier can show that it had a practice or system that is fair and, notwithstanding that the Berne Three Step Test prohibits exceptions that “conflict with a normal exploitation” of the work, a use can be considered “fair” even if it has an adverse effect on the market for the work.[4] Canada’s courts’ tectonic shift away from encouraging payment for uses of copyright… [read post]
11 Nov 2018, 7:18 am by Schachtman
”7          * * * * * * * “In conclusion, this hypothesis generating case report provides additional support for the suggestion that exposure to chemicals that share common mechanisms of action with those implicated in the pathogenesis of ALS type neuromuscular disorders can unmask latent disease in susceptible persons. [read post]
27 Oct 2018, 10:00 pm
ENTHONE, INC., came out from the Court of Appeal of the Federal Circuit (CAFC) last Friday, and reminded me of a good tip: include evidence in the record to show that the claims relate to an unpredictable art. [read post]
12 Oct 2018, 8:00 am by Robert Kreisman
Parikh’s counsel compounded the impropriety by subsequently asking the jury to take “[t]ake yourself back to that time and evaluate for Dr. [read post]
10 Sep 2018, 10:17 am by Lawrence B. Ebert
Roxane was that Acorda lost:Roxane Laboratories, Inc.; Mylan Pharmaceuticals,Inc.; and Teva Pharmaceuticals USA, Inc., have submittedAbbreviated New Drug Applications seeking FDAapproval to market generic versions of Ampyra. [read post]